Kevin DAmour

Insider Reports History

Location
Brooklyn, NY
Signature
/s/ Kevin D'Amour
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin DAmour:

Company Role Class Num Shares Value Price $ Report Date Ownership
Brooklyn ImmunoTherapeutics, Inc. Chief Scientific Officer Restricted Stock Units 52,717 $130,738 $2.48 28 Jun 2022 Direct
Brooklyn ImmunoTherapeutics, Inc. Chief Scientific Officer Common Stock 11,496 $28,510 $2.48 28 Jun 2022 Direct

Insider Reports Filed by Kevin DAmour

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ERNA Brooklyn ImmunoTherapeutics, Inc. 28 Jun 2022 3 -$3,363 4 Chief Scientific Officer 29 Jun 2022, 20:01
ERNA Brooklyn ImmunoTherapeutics, Inc. 11 Mar 2022 1 $0 4/A Chief Scientific Officer 17 Mar 2022, 21:00
ERNA Brooklyn ImmunoTherapeutics, Inc. 28 Jun 2021 2 $0 4 Chief Scientific Officer 30 Jun 2021, 21:34
ERNA Brooklyn ImmunoTherapeutics, Inc. 28 Jun 2021 0 $0 3 Chief Scientific Officer. Exhibit List: Exhibit 24 - Power of Attorney 30 Jun 2021, 21:33